Welcome - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.

Advanced


	Select a currency for use throughout the site

Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure

Site License
Enterprisewide
Site License
Enterprisewide

Live Chat Live Help Software for Website

U.S. Asthma/COPD Market 2011

Frost & Sullivan, April 2011, Pages: 114


	Description



		Table of Contents


		Enquire before Buying


		Send to a Friend

This research service provides an in depth analysis of factors affecting the growth of the U.S. asthma/COPD market over the period 2006-2016. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts, and market share analysis. The market is segmented by mechanisms of action: anti-inflammatories, bronchodilators, and combination therapies. Major market challenges, drivers, and restraints and identified and discussed. Included are examinations of therapeutic candidates in the asthma/COPD pipeline for phase III.

Product samples

A sample for this product is available. Please Login/Register to download this sample.

For enquiries please call us on:

+353-1-415-1241 (GMT Office Hours)

1-800-526-8630 (US/Canada Toll Free)

1-917-300-0470 (EST Office Hours)